MAP3K8 antibody (AA 35-84)
Quick Overview for MAP3K8 antibody (AA 35-84) (ABIN6742194)
Target
See all MAP3K8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 35-84
-
Specificity
- Human MAP3K8
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%) Horse (86%) Mouse (84%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa35-84 of human MAP3K8 (P41279, NP_005195). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%), Marmoset (93%), Galago, Bat, Elephant, Horse (86%), Mouse (84%), Panda (80%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Alternative Name
- MAP3K8 / TPL2
-
Background
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
Gene ID
- 1326
-
NCBI Accession
- NP_005195
-
UniProt
- P41279
-
Pathways
- PI3K-Akt Signaling, TCR Signaling
Target
-